Psychedelics Incannex secures financing deal valued at US$60 million It will fund clinical trials that are currently underway and general corporate expenses Rowan DunneSeptember 10, 2024
Medical and Pharmaceutical Why are Viridian Therapeutics shares on the rise on Tuesday? Veligrotug’s response rate and metrics suggest competitive, and potentially superior, performance than drug presently on the market Joseph MortonSeptember 10, 2024
Medical and Pharmaceutical AstraZeneca shares slide on disappointing lung cancer drug trial results "Dato-DXd" was thought to have immense potential but now appears to be a disappointment Rowan DunneSeptember 10, 2024
Gold Kinross Gold PEA promises high value margins in hot gold market The project promises substantial margins given the current gold price environment Joseph MortonSeptember 10, 2024
Gold Calibre Mining strikes gold: new high-grade discovery at Nicaragua’s Limon Mine Core assays from the newly discovered zone yielded up to 33.5 g/t Au Rowan DunneSeptember 10, 2024
Bitcoin Americans lost $5.6B to cryptocurrency fraud in 2023: FBI report Victims of financial fraud involving cryptocurrencies filed nearly 70,000 complaints with the FBI in 2023 Joseph MortonSeptember 9, 2024
Cannabis Trump voices support for federal rescheduling and banking access A number of cannabis stocks rose significantly after his post on Truth Social Sunday night Rowan DunneSeptember 9, 2024
Health & Wellness Relay Therapeutics shares soar on positive results for breast cancer treatment Several analysts upgraded their price targets for Relay Therapeutics based on the release Joseph MortonSeptember 9, 2024
Gold Calibre Mining shows analysts the ropes at the Valentine gold project Renowned mining industry analyst Paul Harris was one of the tour attendees last week Rowan DunneSeptember 9, 2024
Medical and Pharmaceutical Summit Therapeutics up 55% as lung cancer drug outperforms Merck’s Analysts have now given the company a much higher share target price too Rowan DunneSeptember 9, 2024